Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol.

Mueller, Ruediger B; Spaeth, Michael; von Restorff, Cord; Ackermann, Christoph; Schulze-Koops, Hendrik; von Kempis, Johannes

Mueller, Ruediger B; Spaeth, Michael; von Restorff, Cord; Ackermann, Christoph; Schulze-Koops, Hendrik; von Kempis, Johannes.

Afiliação

Mueller RB; Division of Rheumatology and Immunology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland. Ruediger.Mueller@ksa.ch.
Spaeth M; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians-University Munich, 80336 Munich, Germany. Ruediger.Mueller@ksa.ch.
von Restorff C; Division of Rheumatology, Medical University Department, Kantonsspital Aarau, CH-5001 Aarau, Switzerland. Ruediger.Mueller@ksa.ch.
Ackermann C; Division of Rheumatology, Spital Linth, 8730 Uznach, Switzerland. michael.spaeth@spital-linth.ch.
Schulze-Koops H; Medical practice, 8708 Männedorf, Switzerland. vonrestorff@hin.ch.
von Kempis J; Medical practice, 9495 Triesen, Liechtenstein. ackermann.c@gmx.net.

J Clin Med ; 8(3)2019 Mar 03.

Article em En | MEDLINE | ID: mdl-30832414

Palavras-chave

ACR response; DAS 28; HAQ-DI; certolizumab pegol; csDMARDs; glucocorticoids; intra-articular injections; rheumatoid arthritis; treat-to-target

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article